Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Hypothalamic obesity in childhood-onset (CO-) craniopharyngioma patients may predispose to nonalcoholic fatty liver disease (NAFLD). This study reviewed the characteristics of NAFLD associated with CO-craniopharyngioma. Methods: This study retrospectively reviewed 75 patients who underwent surgery for craniopharyngioma while younger than 15 years of age between 2000 and 2016. Results: Elevated aspartate aminotransferase (AST) or alanine aminotransferase (ALT) above 40 IU/L was observed in 51 of the 75 (68%) CO-craniopharyngioma patients. Imaging studies were performed in 32 patients with elevated liver enzymes. The estimated prevalence of NAFLD in CO-craniopharyngioma was 47%. NAFLD was detected in 22 patients (male 59%, 4.3±4.0 years after first surgery). The mean age at the time of the initial operation was 9.1±2.9 years. Six patients (27.3%) were diagnosed within 1 year. Among the 19 patients with initial height and weight data, the body mass index (BMI) z-score (BMI_Z) at the time of diagnosis with NAFLD was 1.37±1.01 (range, -0.75 to 3.18), with 4 patients (18.2%) being overweight and 9 (40.9%) being obese. BMI_Z increased above BMI_Z at the time of the operation in 13 patients (68.4%). The increment in BMI_Z was 1.13 (range, 0.10–2.84). Seventeen patients did not receive growth hormone. An insulin-like growth factor-I level <3rd percentile was observed in 19 patients. Conclusion: NAFLD is common in survivors of CO-craniopharyngioma and may develop earlier. If the ALT or AST is above 40 IU/L, a diagnostic work-up should be started.
Abstract
Purpose: Hypothalamic obesity in childhood-onset (CO-) craniopharyngioma patients may predispose to nonalcoholic fatty liver disease (NAFLD). This study reviewed the characteristics of NAFLD associated with CO-craniopharyngioma. Methods: This study retrospectively reviewed 75 patients who underwent surgery for craniopharyngioma while younger than 15 years of age between 2000 and 2016. Results: Elevated aspartate aminotransferase (AST) or alanine aminotransferase (ALT) above 40 IU/L was observed in 51 of the 75 (68%) CO-craniopharyngioma patients. Imaging studies were performed in 32 patients with elevated liver enzymes. The estimated prevalence of NAFLD in CO-craniopharyngioma was 47%. NAFLD was detected in 22 patients (male 59%, 4.3±4.0 years after first surgery). The mean age at the time of the initial operation was 9.1±2.9 years. Six patients (27.3%) were diagnosed within 1 year. Among the 19 patients with initial height and weight data, the body mass index (BMI) z-score (BMI_Z) at the time of diagnosis with NAFLD was 1.37±1.01 (range, -0.75 to 3.18), with 4 patients (18.2%) being overweight and 9 (40.9%) being obese. BMI_Z increased above BMI_Z at the time of the operation in 13 patients (68.4%). The increment in BMI_Z was 1.13 (range, 0.10–2.84). Seventeen patients did not receive growth hormone. An insulin-like growth factor-I level <3rd percentile was observed in 19 patients. Conclusion: NAFLD is common in survivors of CO-craniopharyngioma and may develop earlier. If the ALT or AST is above 40 IU/L, a diagnostic work-up should be started.
참고문헌 (36)
- Müller HL, "Craniopharyngioma", Endocr Rev, 35, pp.513~543 (2014)
- Sterkenburg AS, "Survival, hypothalamic obesity, and neuropsychological", psychosocial status after childhood-onset craniopharyngioma: newly reported longterm outcomes, 2015, pp.17, 1029~1038
- 김자혜, "Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents", Annals of Pediatirc Endocrinology & Metabolism, 18(4), pp.161~167 (2013), 대한소아내분비학회
- Iughetti L, "Obesity and craniopharyngioma", Ital J Pediatr, 37, pp.38~ (2013)
- Lustig RH, "Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment", Front Endocrinol (Lausanne), 2, pp.60~ (2011)
- Della Corte C, "Fatty liver disease and obesity in youth", Curr Opin Endocrinol Diabetes Obes, 23, pp.66~71 (2016)
- Hoffmann A, "Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma", Eur J Endocrinol, 173, pp.389~397 (2015)
- 고재성, "비알코올성 지방간질환", 대한소화기학회지, 56(1), pp.6~14 (2010), 대한소화기학회
- Lang IA, "Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults", JAMA, 300, pp.1303~1310 (2008)
- 윤정민, "Nonalcoholic Fatty Liver Disease in Children with Hypopituitarism", Pediatric Gastroenterology, Hepatology & Nutrition, 13(1), pp.51~57 (2010), 대한소아소화기영양학회
- Marino L, "Endocrine causes of nonalcoholic fatty liver disease", World J Gastroenterol, 21, pp.11053~11076 (2015)
- Müller HL, "Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: result s of the mul t inat ional prospect ive t r ial KRANIOPHARYNGEOM 2000 after 3-year follow-up", Eur J Endocrinol, 165, pp.17~24 (2011)
- Kendall-Taylor P, "The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma", Eur J Endocrinol, 152, pp.557~567 (2005)
- Park SW, "Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma", J Neurooncol, 113, pp.417~424 (2013)
- 문진수, "2007 한국 소아 청소년 성장도표 : 개발 과정과 전망", Korean Journal of Pediatrics, 51(1), pp.1~25 (2008), 대한소아과학회
- Hyun SE, "Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents", Clin Biochem, 45, pp.16~21 (2012)
- Park JH, "Alanine aminotransferase and metabolic syndrome in adolescents: the Korean National Health and Nutrition Examination Survey Study", Pediatr Obes, 9, pp.411~418 (2014)
- Berardis S, "Pediatric non-alcoholic fatty liver disease: an increasing public health issue", Eur J Pediatr, 173, pp.131~139 (2014)
- Crom DB, "Health status in long-term survivors of pediatric craniopharyngiomas", J Neurosci Nurs, 42, pp.323~328 (2010)
- Mofrad P, "Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values", Hepatology, 37, pp.1286~1292 (2003)
- Charlton MR, "Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States", Gastroenterology, 141, pp.1249~1253 (2011)
- Jonathan Temple, "A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence", International Journal of Molecular Sciences, 17(6), pp.E947~ (2016), MDPI AG[DOI]
- Holterman A, "Nonalcoholic fatty liver disease and bariatric surgery in adolescents", Semin Pediatr Surg, 23, pp.49~57 (2014)
- Holterman AX, "Nonalcoholic fatty liver disease in severely obese adolescent and adult patients", Obesity (Silver Spring), 21, pp.591~597 (2013)
- Feldstein AE, "The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years", Gut, 58, pp.1538~1544 (2009)
- Adams LA, "Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction", Hepatology, 39, pp.909~914 (2004)
- Holmer H, "Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma", J Clin Endocrinol Metab, 95, pp.5395~5402 (2010)
- Simoneau-Roy J, "Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma", Clin Endocrinol (Oxf), 72, pp.364~370 (2010)
- Srinivasan S, "Features of the metabolic syndrome after childhood craniopharyngioma", J Clin Endocrinol Metab, 89, pp.81~86 (2004)
- Sahakitrungruang T, "Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery", Eur J Pediatr, 170, pp.763~769 (2011)
- Wainwright P, "Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome", Int J Mol Sci, 17, pp.367~ (2016)
- Hong JW, "Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men", Horm Metab Res, 43, pp.48~54 (2011)
- Matsumoto R, "Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency", Growth Horm IGF Res, 24, pp.174~179 (2014)
- Geffner M, "Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database)", J Clin Endocrinol Metab, 89, pp.5435~5440 (2004)
- Hribal ML, "Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease", J Clin Endocrinol Metab, 98, pp.E304~E308 (2013)
- Schwimmer JB, "Clinical advances in pediatric nonalcoholic fatty liver disease", Hepatology, 63, pp.1718~1725 (2016)
